Singapore’s largest and leading co-working laboratory & office space.
Employees: 1-10
Total raised: $14.5M
Founded date: 2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.05.2024 | Series C | $14.5M | - |
Mentions in press and media 16
| Date | Title | Description |
| 13.06.2024 | NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore | Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestone... |
| 12.06.2024 | NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore | Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestone... |
| 12.05.2024 | NSG BioLabs: A Catalyst for Biotech Innovation in Singapore and Southeast Asia | NSG BioLabs, a pioneer in co-working lab spaces in Singapore, has been a driving force in nurturing over 40 biotech companies since 2019. These startups have collectively secured nearly US$400 million in funding and achieved significant bus... |
| 11.05.2024 | NSG BioLabs raised $14.5 M funding led by Celadon Partners | The largest provider of biotech co-working lab and office space in Singapore, NSG BioLabs, has successfully closed a $14.5 million financing round. NSG BioLabs said in a statement on Tuesday that the round was led by the Asian private equit... |
| 08.05.2024 | NSG BioLabs Fuels Closes US$14.5M Financing | NSG BioLabs, a Singapore-based provider of biotech co-working laboratory and office space, raised US$14.5M in funding. The round was led by Celadon Partners with participation from ClavystBio. The company intends to use the funds to augment... |
| 08.05.2024 | Deals in brief: Matrak and Runchise secure funding, Earth VC invests in YC-backed HyLight, three major China deals, and more | NewsDeals in brief: NSG BioLabs bags USD 14.5 billion, SoftBank leads Wayve’s Series C round, 12 China and India deals, and more Written by KrASIA Writers NSG BioLabs, SoftBank, Orange, and more led yesterday’s headlines: NSG BioLabs, a pro... |
| 08.05.2024 | NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio | Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestone... |
| 07.05.2024 | NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio | Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestone... |
| 07.05.2024 | Singapore co-working laboratory provider NSG BioLabs raises $14.5m | NSG BioLabs, a Singapore-based provider of biotech co-working laboratories and office spaces, has raised $14.5 million in a financing round led by private equity firm Celadon Partners, and ClavystBio, a life sciences investor and venture bu... |
| 07.05.2024 | Deals in brief: NSG BioLabs bags USD 14.5 million, SoftBank leads Wayve’s Series C round, 12 China and India deals, and more | NewsDeals in brief: Brainfish and Jejakin secure fresh funding, Ai Palette extends Series A1 round, six China deals, and more Written by KrASIA Writers Brainfish, Jejakin, Ai Palette, and more led yesterday’s headlines: Brainfish, a Sydney-... |
Show more